|
1
|
Terzic J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology.
138:2101–2114.e5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li W, Cai S, Wang L, Yang C, Zhou B and
Wang H: HINT2 downregulation promotes colorectal carcinoma
migration and metastasis. Oncotarget. 8:13521–13531.
2017.PubMed/NCBI
|
|
4
|
Mathot L, Kundu S, Ljungström V, Svedlund
J, Moens L, Adlerteg T, Falk-Sörqvist E, Rendo V, Bellomo C,
Mayrhofer M, et al: Somatic ephrin receptor mutations are
associated with metastasis in primary colorectal cancer. Cancer
Res. 77:1730–1740. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Elabd S, Meroni G and Blattner C: TRIMming
p53s anticancer activity. Oncogene. 35:5577–5584. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ozato K, Shin DM, Chang TH and Morse HC
III: TRIM family proteins and their emerging roles in innate
immunity. Nat Rev Immunol. 8:849–860. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomar D and Singh R: TRIM family proteins:
Emerging class of RING E3 ligases as regulator of NF-κB pathway.
Biol Cell. 107:22–40. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hatakeyama S: TRIM proteins and cancer.
Nat Rev Cancer. 11:792–804. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH
and Gao WQ: TRIM59 is up-regulated in gastric tumors, promoting
ubiquitination and degradation of p53. Gastroenterology.
147:1043–1054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhan W, Han T, Zhang C, Xie C, Gan M, Deng
K, Fu M and Wang JB: TRIM59 promotes the proliferation and
migration of non-small cell lung cancer cells by upregulating cell
cycle related proteins. PLoS One. 10:e01425962015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khatamianfar V, Valiyeva F, Rennie PS, Lu
WY, Yang BB, Bauman GS, Moussa M and Xuan JW: TRIM59, a novel
multiple cancer biomarker for immunohistochemical detection of
tumorigenesis. BMJ Open. 2:e0014102012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jorissen RN, Gibbs P, Christie M, Prakash
S, Lipton L, Desai J, Kerr D, Aaltonen LA, Arango D, Kruhøffer M,
et al: Metastasis-associated gene expression changes predict poor
outcomes in patients with Dukes stage B and C colorectal cancer.
Clin Cancer Res. 15:7642–7651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Freeman TJ, Smith JJ, Chen X, Washington
MK, Roland JT, Means AL, Eschrich SA, Yeatman TJ, Deane NG and
Beauchamp RD: Smad4-mediated signaling inhibits intestinal
neoplasia by inhibiting expression of β-catenin. Gastroenterology.
142:562–571.e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong Y, Ho KS, Eu KW and Cheah PY: A
susceptibility gene set for early onset colorectal cancer that
integrates diverse signaling pathways: Implication for
tumorigenesis. Clin Cancer Res. 13:1107–1114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khamas A, Ishikawa T, Shimokawa K, Mogushi
K, Iida S, Ishiguro M, Mizushima H, Tanaka H, Uetake H and Sugihara
K: Screening for epigenetically masked genes in colorectal cancer
Using 5-Aza-2-deoxycytidine, microarray and gene expression
profile. Cancer Genomics Proteomics. 9:67–75. 2012.PubMed/NCBI
|
|
16
|
Lin WY, Wang H, Song X, Zhang SX, Zhou PS,
Sun JM and Li JS: Knockdown of tripartite motif 59 (TRIM59)
inhibits tumor growth in prostate cancer. Eur Rev Med Pharmacol
Sci. 20:4864–4873. 2016.PubMed/NCBI
|
|
17
|
Aierken G, Seyiti A, Alifu M and Kuerban
G: Knockdown of tripartrtite-59 (TRIM59) inhibits cellular
proliferation and migration in human cervical cancer cells. Oncol
Res. 25:381–388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xing P, Liao Z, Ren Z, Zhao J, Song F,
Wang G, Chen K and Yang J: Roles of low-density lipoprotein
receptor-related protein 1 in tumors. Chin J Cancer. 35:62016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koosha S, Alshawsh MA, Looi CY, Seyedan A
and Mohamed Z: An association map on the effect of flavonoids on
the signaling pathways in colorectal cancer. Int J Med Sci.
13:374–385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shu YJ, Weng H, Ye YY, Hu YP, Bao RF, Cao
Y, Wang XA, Zhang F, Xiang SS, Li HF, et al: SPOCK1 as a potential
cancer prognostic marker promotes the proliferation and metastasis
of gallbladder cancer cells by activating the PI3K/AKT pathway. Mol
Cancer. 14:122015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luo D, Wang Y, Huan X, Huang C, Yang C,
Fan H, Xu Z and Yang L: Identification of a synonymous variant in
TRIM59 gene for gastric cancer risk in a Chinese population.
Oncotarget. 8:11507–11516. 2016.
|
|
22
|
Liang J, Xing D, Li Z, Shen J, Zhao H and
Li S: TRIM59 is upregulated and promotes cell proliferation and
migration in human osteosarcoma. Mol Med Rep. 13:5200–5206. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Charni M, Aloni-Grinstein R, Molchadsky A
and Rotter V: p53 on the crossroad between regeneration and cancer.
Cell Death Differ. 24:8–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gack MU, Shin YC, Joo CH, Urano T, Liang
C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, et al: TRIM25
RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated
antiviral activity. Nature. 446:916–920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lerner M, Corcoran M, Cepeda D, Nielsen
ML, Zubarev R, Pontén F, Uhlén M, Hober S, Grandér D and Sangfelt
O: The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3
ubiquitin ligase involved in ERAD. Mol Biol Cell. 18:1670–1682.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deshaies RJ and Joazeiro CA: RING domain
E3 ubiquitin ligases. Annu Rev Biochem. 78:399–434. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Valiyeva F, Jiang F, Elmaadawi A, Moussa
M, Yee SP, Raptis L, Izawa JI, Yang BB, Greenberg NM, Wang F, et
al: Characterization of the oncogenic activity of the novel TRIM59
gene in mouse cancer models. Mol Cancer Ther. 10:1229–1240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kondo T, Watanabe M and Hatakeyama S:
TRIM59 interacts with ECSIT and negatively regulates NF-κB and
IRF-3/7-mediated signal pathways. Biochem Biophys Res Commun.
422:501–507. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Licchesi JD, Van Neste L, Tiwari VK, Cope
L, Lin X, Baylin SB and Herman JG: Transcriptional regulation of
Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene. 29:5923–5934.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dahlmann M, Kobelt D, Walther W, Mudduluru
G and Stein U: S100A4 in cancer metastasis: Wnt signaling-driven
interventions for metastasis restriction. Cancers (Basel).
8:E592016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fodde R, Smits R and Clevers H: APC,
signal transduction and genetic instability in colorectal cancer.
Nat Rev Cancer. 1:55–67. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stein U and Schlag PM: Clinical,
biological, and molecular aspects of metastasis in colorectal
cancer. Recent Results Cancer Res. 176:61–80. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dahlmann M, Okhrimenko A, Marcinkowski P,
Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM and Stein
U: RAGE mediates S100A4-induced cell motility via MAPK/ERK and
hypoxia signaling and is a prognostic biomarker for human
colorectal cancer metastasis. Oncotarget. 5:3220–3233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
